Raskopf, Esther

Publishing since 2004 (Junior)

Has published 14 publications in 7 years

Number of publications published per year by Raskopf, Esther. (Source : PubMed)

Distribution of publications types for Raskopf, Esther. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Raskopf E, Vogt A, Standop J, Sauerbruch T, Schmitz V. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.  Z Gastroenterol  2010;48;1  
•  Raskopf E, Gerceker S, Vogt A, Standop J, Sauerbruch T, Schmitz V. Plasminogen fragment K1-3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver.  Int J Colorectal Dis  2009;24;7  
•  Quante M, Raskopf E, Stahl S, Vogt A, Sauerbruch T, Schmitz V. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.  Oncol. Rep.  2009;21;5  
•  Raskopf E, Vogt A, Sauerbruch T, Schmitz V. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.  J. Hepatol.  2008;49;6  
•  Sass G, Leukel P, Schmitz V, Raskopf E, Ocker M, Neureiter D, Meissnitzer M, Tasika E, Tannapfel A, Tiegs G. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice.  Int. J. Cancer  2008;123;6  
•  Schmitz V, Raskopf E, Gonzalez-Carmona MA, Vogt A, Kornek M, Sauerbruch T, Caselmann WH. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.  Cancer Invest.  2008;26;5  
•  Kornek M, Raskopf E, Tolba R, Becker U, Klöckner M, Sauerbruch T, Schmitz V. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.  Liver Int.  2008;28;4  
•  Schmitz V, Raskopf E, Gonzalez-Carmona MA, Vogt A, Rabe C, Leifeld L, Kornek M, Sauerbruch T, Caselmann WH. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.  Gut  2007;56;2  
•  Kornek M, Raskopf E, Guetgemann I, Ocker M, Gerceker S, Gonzalez-Carmona MA, Rabe C, Sauerbruch T, Schmitz V. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1.  J. Hepatol.  2006;45;3  
•  Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.  Gene Ther.  2006;13;16  

[ See timeline ] [ See all publications ]